Health Canada - Government of Canada
Skip to left navigationSkip over navigation bars to content
Drugs and Health Products

Clinical Trials

arrow Clinical Trials Manual

arrow Notice: To Clinical Trial Sponsors: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant Properties
Date: 2006-07-23

arrow Draft Guidance for Industry: Clinical Trials in Type 2 Diabetes in Canada (Oral Agents)
Date: 2006-07-19

arrow ICH Guidances

arrow Health Canada Addendum to ICH Guidance Document E11: Clinical Investigation of Medicinal Products in the Pediatric Population
Date: 2003-12-17

  E11: Clinical Investigation of Medicinal Products in the Pediatric Population
Date: 2003-12-17

arrow Notice: Release of New Guidance for Clinical Trial Sponsors: Clinical Trial Applications
Date: 2003-06-25

 
arrow Draft Guidance for Industry: Clinical Trial Applications for Comparative Bioavailability Studies for Pharmaceuticals
Date: 2001-10-09

 
arrow Draft Guidance for Clinical Trial Sponsors Quality (Chemistry and Manufacturing): Clinical Trial Applications
Date: 2001-07-18

arrow Inclusion of Women in Clinical Trials
Date: 1997-05-27

Last Updated: 2006-08-02 Top